Future research can further expand upon our findings and consider the external validity of our results through inclusion of different ethnicities, implementation of interventional studies, and measurement of additional biomarkers such as APO-B to enhance the accuracy of prediction in MetS burden. Here, APOB is linked to metabolic syndrome.